New resources on treating opioid, alcohol dependence
The federal Substance Abuse and Mental Health Services Administration (SAMHSA) has developed new clinical guidance on the use of extended-release injectable naltrexone to treat opioid and alcohol dependence disorders. These guides, developed for use by primary care and specialty providers, is available to download at no cost.
Download the Opioid Medication-assisted Treatment Guide
Download the Alcohol Medication-assisted Treatment Guide